haematology
Medicine

No news is good news for G-CSF biosimilars

The biosimilar G-CSF is just as tolerable, effective and safe as the ‘originator’ G-CSF in all indications, according to a review of the literature by German haematologists. Writing in Current Opinion in Hematology the doctors said that no evidence of immunogenicity has emerged nor have seven years of copious use in Europe raised any other ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic